HealthDay on MSN14 小时
Study IDs Signs of Topical Steroid Withdrawal in Atopic Dermatitis
Self-reported manifestations of topical steroid withdrawal (TSW) in atopic dermatitis (AD) include erythema, desquamation, ...
Arcutis Biotherapeutics: After Outstanding 2024, Shares May Face Cooling Off Period
Financial writer analysis of Arcutis Biotherapeutics, Inc. stock surge and potential growth, FDA approvals, and partnerships in 2025. Click for this ARQT update.
SciBase: Nevisense (EIS) included in updated German (S1) imaging guidelines
About SciBase SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care ...
Insider Decision Unfolding At Incyte: Matteo Trotta Exercises Options, Resulting In $0
What Happened: A notable Form 4 filing on Wednesday with the U.S. Securities and Exchange Commission revealed that Trotta, EVP at Incyte, exercised stock options for 0 shares of INCY, resulting in a ...
In A Strategic Move, Christiana Stamoulis Acquires Incyte Stock Options Worth $8K ...
Christiana Stamoulis, EVP & Chief Financial Officer at Incyte INCY, reported acquisition of company stock options on January 22, according to a new SEC filing. What Happened: Stamoulis, EVP & Chief ...
Equities Analysts Issue Forecasts for AbbVie FY2025 Earnings
Investment analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for AbbVie in a report released on Tuesday, ...